MYH9-Related Disease: May-Hegglin, Fechtner, Epstein and Sebastian Syndromes, Giant Platelets and Döhle-Like Bodies, with Quiz

Haematology · Platelet disorders

Four old syndrome names, one gene: how MYH9-related disease presents, what the blood film shows, how to tell it from other inherited macrothrombocytopenias, and why it is so often mistaken for immune thrombocytopenia.

PMPathology MCQ Editorial TeamUpdated Oct 20268 min read
MYH9-related disease cover: blood cell field labelled giant platelets and Döhle-like bodies, Pathology MCQ.
At a glance
  • Gene: MYH9 (22q12.3) encodes non-muscle myosin heavy chain IIA (NMMHC-IIA); autosomal dominant
  • One disease: May-Hegglin anomaly, Fechtner, Epstein and Sebastian syndromes are now grouped as MYH9-related disease (MYH9-RD)
  • Constant feature: macrothrombocytopenia with bleeding milder than the count suggests
  • Blood film: Döhle-like bodies in neutrophils are seen on routine stain in most patients but may be absent; immunofluorescence for NMMHC-IIA picks up all
  • Later features: sensorineural deafness, proteinuric nephropathy, presenile cataracts, raised liver enzymes
  • Pitfall: often misdiagnosed as immune thrombocytopenia

Pathology MCQ app · Android

Get the Pathology MCQ app

Practise haematology with a new MCQ every day.

  • ❓Daily MCQ with explanations and streaks
  • 🔬Virtual slides you pinch-zoom, with annotations
  • 📚Your courses, notes and mocks in one place
Get it onGoogle PlayComing soon to theApp Store

The old syndromes

Mutant NMMHC-IIA disturbs the cytoskeleton of megakaryocytes, so proplatelet formation is ineffective and platelets are released too large and too few. The four classic syndromes differ only in which non-haematological features had appeared when they were described; they are now seen as one spectrum.

Historical names
SyndromeNeutrophil inclusions (routine stain)NephritisDeafnessCataract
May-Hegglin anomalyYes (large, blue)NoNoNo
Sebastian syndromeYes (smaller, ill-defined)NoNoNo
Fechtner syndromeYesYesYesYes
Epstein syndromeNo (abnormal only on immunofluorescence)YesYesNo

Laboratory features

  • Giant platelets: many as large as red cells; mean platelet volume often cannot be measured.
  • Döhle-like bodies: pale blue cytoplasmic inclusions in neutrophils, made of NMMHC-IIA aggregates. They can be small or invisible on a routine stain.
  • Immunofluorescence: staining a blood smear for NMMHC-IIA is the most sensitive screen; the pattern (large clumps, small clumps or diffuse) correlates with the mutation.
  • Platelet count: automated counters undercount giant platelets as red cells; a manual or optical count is more accurate.
  • Platelet function: usually near normal, so bleeding is mild despite low counts.
  • Confirmation: MYH9 sequencing.
Pitfall

Lifelong thrombocytopenia with giant platelets and a family history should prompt a careful film before calling it immune thrombocytopenia. Misdiagnosis leads to useless steroids, immunoglobulin or even splenectomy.

Differential diagnosis: inherited macrothrombocytopenias

Giant platelets are not specific to MYH9-RD. Read the film for white-cell inclusions and granule content, then use function and flow studies to separate the others.

Macrothrombocytopenias compared
DisorderGene and inheritanceBlood film clueBleeding and platelet functionKey test
MYH9-related diseaseMYH9; autosomal dominantGiant platelets; Döhle-like bodies in neutrophils (may be absent)Mild bleeding; function near normalNMMHC-IIA immunofluorescence; MYH9 sequencing
Bernard-Soulier syndromeGP1BA, GP1BB, GP9; usually autosomal recessiveGiant platelets; no white-cell inclusionsModerate to severe mucocutaneous bleeding; no ristocetin agglutination, not corrected by normal plasmaFlow cytometry: reduced CD42b and CD42a
Gray platelet syndromeNBEAL2; autosomal recessiveLarge, pale grey, agranular plateletsMild to moderate bleeding; alpha-granule deficiencyElectron microscopy; marrow fibrosis and splenomegaly are clues
GATA1-related diseaseGATA1; X-linkedLarge, grey platelets with anaemia; dyserythropoiesis in marrowVariable bleedingGATA1 sequencing
ACTN1 or TUBB1-relatedACTN1, TUBB1; autosomal dominantLarge platelets; no inclusionsUsually asymptomatic; function normalSequencing (diagnosis of exclusion)
Immune thrombocytopenia (mimic)AcquiredPlatelets may be mildly large, not giant; no inclusionsBleeding tracks the countExclusion; responds to steroids or immunoglobulin
Exam pearl

Start with platelet size. Small platelets point to Wiskott-Aldrich syndrome. Giant platelets with neutrophil inclusions point to MYH9-RD. Giant platelets without inclusions need ristocetin studies, granule assessment and flow cytometry.

Organ involvement and management

Non-haematological features
OrganFeatureNote
EarSensorineural deafnessThe commonest extra-haematological feature; cochlear implants work well
KidneyProteinuric nephropathy progressing to kidney failureLinked especially to mutations in the head (motor) domain
EyePresenile cataractLess common
LiverMildly raised liver enzymesUsually benign
Key point

Mutations in the head domain (for example at R702) carry the highest risk of nephropathy and early deafness; most tail-domain mutations cause a milder, mainly haematological picture.

Management
  • Avoid steroids, immunoglobulin and splenectomy; they do not help.
  • Before surgery or delivery: platelet transfusion if needed, or a thrombopoietin receptor agonist such as eltrombopag to raise the count.
  • Monitor hearing and urine protein regularly; start an ACE inhibitor or ARB for proteinuria.
  • Offer genetic counselling: 50% risk to each child.

Practice questions

PRACTICE · SBA1 of 10

A young man has lifelong thrombocytopenia, giant platelets, blue inclusions in neutrophils, hearing loss and proteinuria. Which protein is abnormal?

Show answer
Correct: B. MYH9 encodes NMMHC-IIA. Giant platelets, Döhle-like bodies, deafness and nephritis are the old Fechtner or Epstein picture of MYH9-related disease. GPIb is abnormal in Bernard-Soulier syndrome, WASP in Wiskott-Aldrich syndrome and GPIIb/IIIa in Glanzmann thrombasthenia.
PRACTICE · SBA2 of 10

A patient has macrothrombocytopenia, neutrophil Döhle-like bodies, nephritis, sensorineural deafness and cataract. Which historical syndrome does this describe?

Show answer
Correct: D. Fechtner syndrome has all four features. May-Hegglin and Sebastian have only the haematological findings; Epstein has nephritis and deafness without visible inclusions or cataract. Alport syndrome has no thrombocytopenia.
PRACTICE · SBA3 of 10

Why may an automated impedance analyser report a falsely low platelet count in MYH9-related disease?

Show answer
Correct: C. Impedance counters size cells by volume; platelets as big as red cells fall into the red cell channel, so a manual or optical count is needed. Clumping and satellitism also lower counts, but they are artefacts of EDTA, not a feature of MYH9-RD.
PRACTICE · SBA4 of 10

Which test on a peripheral blood smear detects MYH9-related disease even when Döhle-like bodies are not visible on routine stain?

Show answer
Correct: E. Immunofluorescence shows abnormal NMMHC-IIA localisation in neutrophils in all genotypes, including patients whose inclusions are invisible on a routine film. MYH9 sequencing then confirms the diagnosis.
PRACTICE · SBA5 of 10

A child is found to carry an MYH9 R702 head-domain mutation. Which complication should the family be warned about?

Show answer
Correct: A. R702 and other head-domain mutations carry the highest risk of kidney disease and deafness, often before middle age. Tail-domain and truncating mutations usually cause an isolated or mild phenotype. Spontaneous severe bleeding is unusual because platelet function is preserved.
PRACTICE · SBA6 of 10

A 22-year-old has had a platelet count of 35 × 10⁹/L since childhood. Steroids, immunoglobulin and splenectomy for presumed ITP failed. Her mother is deaf with a low platelet count, and the film shows large platelets. What is the best next step?

Show answer
Correct: B. Lifelong low counts, a family history with deafness and large platelets mean an inherited macrothrombocytopenia until proven otherwise. Further immunosuppression is useless.
PRACTICE · SBA7 of 10

A child has giant platelets and mucocutaneous bleeding. Ristocetin does not agglutinate the platelets, and normal plasma does not correct it. There are no neutrophil inclusions. What is the diagnosis?

Show answer
Correct: D. Bernard-Soulier syndrome is GPIb-IX-V deficiency; flow cytometry shows reduced CD42b and CD42a. In Glanzmann thrombasthenia platelets are normal-sized and ristocetin works; in type 2B von Willebrand disease ristocetin response is increased.
PRACTICE · SBA8 of 10

A patient has large, pale grey platelets that lack granules on a Romanowsky stain, with marrow fibrosis and splenomegaly. Which gene is most likely mutated?

Show answer
Correct: E. Gray platelet syndrome is caused by biallelic NBEAL2 mutations that abolish alpha granules. Myelofibrosis and splenomegaly follow because alpha-granule contents leak into the marrow.
PRACTICE · SBA9 of 10

A woman with confirmed MYH9-related disease and a platelet count of 25 × 10⁹/L needs elective surgery. Which is the most appropriate way to raise the count beforehand?

Show answer
Correct: A. Thrombopoietin receptor agonists such as eltrombopag raise counts in MYH9-RD. Steroids, immunoglobulin and rituximab do not work in this non-immune disease, and splenectomy gives little benefit and adds risk. Platelet transfusion covers major bleeding.
PRACTICE · SBA10 of 10

Which statement about MYH9-related disease is correct?

Show answer
Correct: C. The disease is autosomal dominant. Absent ristocetin agglutination is Bernard-Soulier syndrome. Megakaryocytes are normal or increased, because the defect is ineffective proplatelet formation, and the count stays low throughout life.

Pathology MCQ app · Android

Get the Pathology MCQ app

Practise a slide and an MCQ every day, even when you are away from your desk.

  • ❓Daily MCQ with explanations and streaks
  • 🔬Virtual slides you pinch-zoom, with annotations
  • 📚Your courses, notes and mocks in one place
Get it onGoogle PlayComing soon to theApp Store
Key takeaways
  • MYH9 encodes NMMHC-IIA; the disease is autosomal dominant.
  • May-Hegglin, Sebastian, Fechtner and Epstein are one spectrum: MYH9-related disease.
  • Giant platelets are constant; Döhle-like bodies are usually but not always visible, and immunofluorescence finds the rest.
  • Deafness, nephritis and cataract may follow, mainly with head-domain mutations such as R702.
  • Do not mistake it for immune thrombocytopenia; count platelets manually and avoid steroids and splenectomy.
  • Bernard-Soulier syndrome, gray platelet syndrome and GATA1-related disease are the main giant-platelet mimics.
References

Pecci A, Ma X, Savoia A, Adelstein RS. MYH9: structure, functions and role of non-muscle myosin IIA in human disease. Gene 2018;664:152–167 · Balduini CL, Pecci A, Savoia A. Recent advances in the understanding and management of MYH9-related inherited thrombocytopenias. Br J Haematol 2011;154:161–174 · Pecci A, Klersy C, Gresele P, et al. MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations. Hum Mutat 2014;35:236–247 · Pecci A, Gresele P, Klersy C, et al. Eltrombopag for the treatment of the inherited thrombocytopenia deriving from MYH9 mutations. Blood 2010;116:5832–5837 · Bain BJ. Blood Cells: A Practical Guide, 6th ed. Wiley-Blackwell; 2022

PM

Pathology MCQ Editorial TeamWritten and reviewed by practising pathologists who teach FRCPath, NEET-SS, INI-SS and MD/DNB candidates.

Practice bank

High-Yield, Board-Style Image MCQs & Interactive Whole Slide Images

High-resolution virtual microscopy with questions aligned to ABP, FRCPath, NEET-SS, DM Hematopathology and MD/DNB.


Discover more from PATHOLOGY MCQs

Subscribe to get the latest posts sent to your email.

Leave a Reply

You cannot copy content of this page

Discover more from PATHOLOGY MCQs

Subscribe now to keep reading and get access to the full archive.

Continue reading